Abstract
Forty-nine patients with breast cancer having bone metastasis treated at the department from 1970 to 1989 were subjected to a study of factors influencing the post-relapse survival. In this study patients in stage IV or those associated with visceral were excluded. The results were as follows.
(1) Post-relapse survival rates were the same regardless of the kind of initial therapy. (2) There was also no significant difference in the survival period between responders and non-responders to the therapy. (3) The survival rate in the patients with disease-free interval (DFI) of over 2 years was significantly better than that with DFI of less than 2 years.
